Walgreens and AmerisourceBergen agree to $6.5B wholesale pharmacy sale

Walgreens Boots Alliance is offering off the majority of its wholesale pharmacy enterprise, Alliance Health care, to AmerisourceBergen in a offer value around $six.five billion, the two providers have declared.

Walgreens will receive $six.275 billion in cash and 2 million shares of AmerisourceBergen common inventory.

In addition to the transaction, the providers are extending their U.S. distribution settlement until eventually 2029 and Alliance Health care British isles will remain the distribution spouse of Boots until eventually 2031.

The offer is expected to shut by the conclude of AmerisourceBergen’s fiscal yr 2021 and is subject to the gratification of regulatory approvals.

What is THE Effect

As a single of the premier pharmaceutical wholesalers in Europe, Alliance Health care will increase AmerisourceBergen’s wholesale, distribution and linked answers abilities, in the end increasing the breadth and depth of its international manufacturer solutions, AmerisourceBergen president and CEO Steven Collis said in the announcement.

The sale will enable Walgreens to concentrate on its retail pharmacy and health care businesses, which in new months has involved a foray into principal treatment. The retailer has a offer with VillageMD to open five hundred to 700 clinics in Walgreens areas above the upcoming five a long time.

THE Greater Pattern

By liberating by itself up to put far more energy into its other businesses, Walgreens will be superior outfitted to contend with the likes of CVS and Walmart, the two of which have also started moving in to the principal treatment space.

By the conclude of the yr, CVS hopes to have opened a different 1,five hundred HealthHubs.

Walmart has been operating on increasing its treatment facilities and will open an more 22 amenities by the conclude of 2021.

For its component, Walgreens not long ago declared designs to open forty new entire-company principal treatment clinics by the conclude of this summer months.

Walgreens declared its 2021 very first-quarter final results on Thursday, as nicely. It introduced in $36.3 billion in gross sales, an boost of five.seven% yr-above-above, and experienced an running loss of $440 million thanks to a $1.five billion charge from the firm’s equity earnings in AmerisourceBergen.

General, the very first quarter final results yielded small single-digit advancement in modified earnings for every share at consistent currency charges and “exceeded anticipations, reflecting strength in Boots British isles and Boots Opticians,” in accordance to the announcement.


“This strategic settlement with AmerisourceBergen, which we take into consideration to be the world’s major pharmaceutical wholesaler, is a pretty good progress for the two providers. This offer will enable important worth development for the two providers and will create new synergies in addition to those people now captured. It is a logical move next the results of our prolonged-time period strategic partnership with AmerisourceBergen which has been a robust and trustworthy spouse considering the fact that 2013,” said Stefano Pessina, executive vice chairman and CEO of Walgreens Boots Alliance. “The transaction will gas bigger potential investments to increase and completely transform our core retail pharmacy and health care businesses, and is EPS accretive prolonged-time period for Walgreens Boots Alliance.”

Twitter: @HackettMallory
Email the author: [email protected]